Incyte-backed trials: OSU tests pemigatinib cycling regimen; OHSU starts Opzelura pilot for PGAug 24Weekly roundup, 2 itemsIncyte Corporationpemigatinib
Karyopharm says myelofibrosis sNDA submission remains on track for AugustAug 13Quarterly updateKaryopharm Therapeutics Inc
Syndax reports 2Q26 revenue growth, details EGFR and menin inhibitor pipeline additionsAug 4Quarterly updaterevumenibSyndax Pharmaceuticals Inc
Incyte raises 2026 sales guidance, adds ten data readouts, closes Vega dealJul 28Quarterly updateIncyte Corporation
Merck registers Phase 2/3 trial of bomedemstat versus standard therapies in polycythemia veraJul 23Trial updateMerck & Co., Inc.
BMS trials post results across lung cancer, sarcoma, myelofibrosis; new stroke study opensJul 17Weekly roundup, 5 itemsBristol Myers Squibblisocabtagene maraleucel
Incyte-linked ruxolitinib trials post results; both MGH and UT Southwestern studies reportJul 9Weekly roundup, 2 itemsIncyte Corporationruxolitinib
Sign inSign in